Residual neuromuscular block in type II diabetes mellitus after rocuronium: a prospective observational study.

Background: Diabetes mellitus causes motor nerve dysfunction and degeneration that may alter the response to neuromuscular blocking drugs.

Objective: To analyse the risk of residual neuromuscular block (RNMB) induced by rocuronium given in standard doses to patients with type 2 diabetes mellitus (T2DM).

Design: A prospective, observational study.